A review on novel therapeutic strategies for the enhancement of solubility for hydrophobic drugs through lipid and surfactant based self micro emulsifying drug delivery system: A novel approach

American Journal of Drug Discovery and Development

Volumn 2, Issue 4, 2012, Pages 143-183

  Agrawal, Sarita ^a   Giri, Tapan Kumar ^a   Tripathi, Dulal Krishna ^a   Ajazuddin, ^a   Alexander, Amit ^a  

^a Rugnta College of Pharmaceutical Sciences and Research   (India)

Author keywords

Bioavailability; Cosolvent; Lipophilic; Self emulsification; Smedds; Solubility enhancement

Indexed keywords

ACICLOVIR; BICALUTAMIDE; BUFALIN; CELECOXIB; DEXIBUPROFEN; ETODOLAC; EXCIPIENT; GLYCYRRHIZIC ACID; INDOMETACIN; KETOPROFEN; NIFEDIPINE; OIL; ORIDONIN; PACLITAXEL; POLYMER; SILIBININ; SILYMARIN; SIMVASTATIN; SORAFENIB; SURFACTANT; VALSARTAN; VINPOCETINE; WATER OIL CREAM;

AREA UNDER THE CURVE; CONTROLLED DRUG RELEASE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STABILITY; HUMAN; HYDROPHOBICITY; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; INTESTINE TRANSIT TIME; LIPOSOMAL DELIVERY; MAXIMUM PLASMA CONCENTRATION; MICROEMULSION; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PHASE SEPARATION; REFRACTION INDEX; REVIEW; SELF MICROEMULSIFYING DRUG DELIVERY SYSTEM; SUSTAINED DRUG RELEASE; TIME TO MAXIMUM PLASMA CONCENTRATION; ZETA POTENTIAL;

EID: 84861219159     PISSN: 2150427X     EISSN: 21504296     Source Type: Journal    
DOI: 10.3923/ajdd.2012.143.183     Document Type: Review

References (162)

1. Abbasalipourkabir, R., A. Salehzadeh and R. Abdullah, 2011. Cytotoxicity effect of solid lipid nanoparticles on human breast cancer cell lines. Biotechnology, 10: 528-533.
2. Abdalla, A. and K. Mader, 2007. Preparation and characterization of a self emulsifying pellet formulation. Eur. J. Pharm. Biopharm., 66: 220-226.
3. Abdalla, A., S. Klein and K. Mader, 2008. A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: Characterization, dissolution, in vitro digestion and incorporation into solid pellets. Eur. J. Pharm. Sci., 35: 457-464.
4. Agarwal, V., A. Siddiqui, H. Ah and S. Nazzal, 2009. Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS). Int. J. Pharm., 366: 44-52.
5. Ajazuddinm, S.S., 2010. Applications of novel drug delivery system for herbal formulations. Fitoterapia, 81: 680-689.
6. Alexander, A., M. Ajazuddin, M. Swarna, M. Sharma and D.K. Tripathi, 2011. Polymers and permeation enhancers: specialized components of mucoadhesives. Stamford J. Pharm. Sci., 4: 91-95.
7. Amarji, B., Ajazuddin, D. Raghuwanshi, S.P. Vyas and P. Kanaujia, 2007. Lipid nano spheres (LNSs) for enhanced oral bioavailability of amphotericin B: Development and characterization. J. Biomed. Nanotechnol., 3: 264-269.
8. Angare, D., T. Giri, D.K. Tripathi, A. Alexander and Ajazuddin, 2012. Unexplored Areas and new findings in lipid emulsion serving as a potential drug carrier for liphophilic drugs: A review. Trends Med. Res., 7: 1-24.
9. Anisa, A.N.I., A.H. Nour and A.H. Nour, 2010. Catastrophic and transitional phase inversion of water-in-oil emulsion for heavy and light crude oil. J. Applied Sci., 10: 3076-3083.
10. Aqil, F., M. Zahm, K.A. EI Sayed, I. Ahmad, K.Y. Orabi and J.M. Arif, 2011. Antimicrobial, antioxidant, and antimutagenic activities of selected marine natural products and tobacco cembranoids. Drug Chem. Toxicol., 34: 167-179.
11. Arif, J.M., I. Ahmad and Q. Rahman, 1996. Chrysotile inhibits glutathione-dependent protection against the onset of lipid peroxidation in rat lung microsomes. Pharmacol. Toxicol., 79: 205-210.
12. Atef, E. and A.A. Belmonte, 2008. Formulation and in vitro and in vivo characterization of a Phenytoin self-emulsifying drug delivery system (SEDDS). Eur. J. Pharm. Sei., 35: 257-263.
13. Attama, A.A., 2003. The use of solid self-emulsifying systems in the delivery of diclofenac. Int. J. Pharm., 262: 23-28.
14. Attama, A.A. and M.O. Nkemnele, 2005. In vitro evaluation of drug release from self micro- emulsifying drug delivery systems using a novel biodegradable homolipid from Capra hircus. Int. J. Pharm., 304: 4-10.
15. Aungst, B.J., 2000. Intestinal permeation enhancers. J. Pharm. Sei., 89: 429-442.
16. Bachhav, Y.G. and V. B. Patravale, 2009. SMEDDS of Glyburide: Formulation, in vitro evaluation and stability studies. AAPS Pharm. Sei. Tech., 10: 482-487.
17. Badawi, A.A., M.A. El-Nabarawi, D.A. El-Setouhy and S.A. Alsammit, 2011. Characterization and stability testing of itraconazole solid dispersions containing crystallization inhibitors. Am. J. Drug Discovery Dev., 1: 144-159.
18. Balakrishnan, P., B.J. Lee, D.H. Oh, J.O. Kim and M.J. Hong et al, 2009. Enhanced oral bioavailability of dexibuprofen by a novel solid S elf-Emulsifying Drug Delivery System (SEDDS). Eur. J. Pharm. Biopharm., 72: 539-545.
19. Barakat, N.S., 2010. S elf-emulsifying system for improving drug dissolution and bioavailability: In vitro/in vivo evaluation. Drug Dev. Res., 71: 149-158.
20. Barthélémy, P. and H. Benameur, 2001. Composition with sustained release of active principle capable of forming microemulsion. United State Patent 6309665.
21. Benameur, H., V. Jannin and D. Roulot, 2003. Method and formulation for decreasing statin metabohsm. US Patent 6652865.
22. Benet, L.Z. and C.L. Cummins, 2001. The drug efflux-metabolism alliance: Biochemical aspects. Adv. Drug Dehv. Rev., 50: S3-S11.
23. Borhade, V., H. Nair and D. Hegde, 2008. Design and evaluation of s elf-microemulsifying drug delivery system (SMEDDS) of tacrolimus. AAPS Pharm. Sei. Tech., 9: 13-21.
24. Burcham, D.L., M.B. Maurin, E.A. Hausner and S.M. Huang, 1997. Improved oral bioavailability of the hypocholesterolemic DMP 565 in dogs following oral dosing in oil and glycol solutions. Biopharm. Drug Dispos., 18: 737-742.
25. Carrigan, P.J. and T.R. Bates, 1973. Biopharmaceutics of drugs administered in lipid-containing dosage forms: Gl absorption of griseofulvin from oil in water emulsion in the rat. J. Pharm. Sei., 62: 1476-1479.
26. Chakraborty, S., D. Shukla, B. Mishra and S. Singh, 2009. Lipid: An emerging platform for oral delivery of drugs with poor bioavailability. Eur. J. Pharm. Biopharm., 73: 1-15.
27. Charman, S.A., W.N. Charman, M.C. Rogge, T.D. Wilson, F.J. Dutko and C.W. Pouton, 1992. Self- emulsifying drug delivery systems: formulation and biopharmaceutical evaluation of an investigational lipophillic compound. Pharm. Res., 9: 87-93.
28. Chen, Y., H. Zhang, H. Wang and K. Yang, 2011. Effects of Dietary Addition of Non-lomc Surfactants on Ruminai Metabolism and Nutrient Digestion of Chinese Merino Sheep Asian J. Anim. Vet. Adv., 6: 688-696.
29. Chitnem, M., K.K. Peh, Y. Darwis, M. Abdulkarim, GZ. Abdullah and M.J. Qureshi, 2011. Intestinal permeability studies of sulpiride incorporated into Self-Microemulsifying Drug Delivery System (SMEDDS). Pak. J. Pharm. Sei., 24: 113-121.
30. Cirri, M., P. Mura and P.C. Mora, 2007. Liquid spray formulations of xibornol by using self- micro emulsifying drug delivery systems. Int. J. Pharm., 340: 84-91.
31. Constantinides, P.P., 1995. Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects. Pharm. Res., 12: 1561-1572.
32. Craig, D.Q.M., 1993. The use of self-emulsifying systems as a means of improving drug delivery. B.T. Gattefosse, 86: 21-31.
33. Craig, D.Q.M., S.A. Barker, D. Bannmg and S.W. Booth, 1995. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int. J. Pharm., 114: 103-110.
34. Cui, J., B. Yu, Y. Zhao, W. Zhu, H. Li, H. Lou and G. Zhai, 2009. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int. J. Pharm., 371: 148-155.
35. Cui, S., C. Zhao, D. Chen and Z. He, 2005. Self-Microemulsifying drug delivery systems (SMEDDS) for improving/ti Vitro dissolution and oral absorption oiPueraria Zo6aia isoflavone. Drug Dev. Ind. Pharm., 31: 349-356.
36. Cm, S.X., S.F. Nie, L. Li, C.G Wang, W.S. Pan and J.P. Sun, 2009. Preparation and evaluation of self-microemulsifying drug delivery system containing vinopocetine. Drug Dev. Ind. Pharm., 35: 603-611.
37. Date, A.A. and M.S. Nagarsenker, 2007. Design and evaluation of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for cefpodoxime proxetil. Int. J. Pharm., 329: 166-172.
38. De Gennes, P.G. and C. Taupin, 1982. Microemulsions and the flexibility of oil/water interfaces. J. Phys. Chem., 86: 2294-2304.
39. Noudeh, G.D., P. Khazaeli and P. Rahmani, 2008. Study of the effects of polyethylene glycol sorbitan esters surfactants group on biological membranes. Int. J. Pharmocol., 4: 27-33.
40. Devani, M., M. Ashford and D.Q. Craig, 2004. The emulsification and solubilisation properties of polyglycolysed oils in self-emulsifying formulations. J. Pharm. Pharmacol., 56: 307-316.
41. Dey, P., S. Maiti, S. Ray, B. Sa and K. Sen, 2009. Self emulsification of poorly soluble and highly permeable drugs: An overview. Int. J. Pharm. Recent Res., 1: 67-72.
42. Dhingra, O., 2011. Modulation of solubility, stability, absorption, metabolism and pharmacokinetic profile of lipophilic drugs by sterols. US Patent Application 20110160168, http://www.freepatentsonhne.eom/y2011/0160168.html
43. Dintaman, J.M. and J.A. Silverman, 1999. Inhibition of P-glycoprotein by Dalpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm. Res., 16: 1550-1556.
44. Dixit, A.R., S.J. Rajput and S.G. Patel, 2010. Preparation and bioavailability assessment of SMEDDS containing valsartan. AAPS Pharm Sci Tech., 11: 314-321.
45. Farah, N., J.P. Laforet and J. Denis, 1994. Self-Micro Emulsifying Drug Delivery Systems (SMEDDS) for improving dissolution and bioavailability of poorly soluble ac-tiveingredients. B. T. Gattefosse, 87: 41-47.
46. Farah, N. and J. Denis, 2001. Orally administrable composition capable of providing enhanced bioavailability when ingested. US Patent 6312704, http://www.googIe.com/patents/US6312704
47. Friedman, D., 2007. Non-aqueous compositions for oral delivery of insoluble bioactive agents. US Patent Application 20070190080, http://www.googIe.eom/patents/US20070190080
48. Gao, P., B.D. Rush, W.P. Pfund, T. Huang and J.M. Bauer et al, 2003. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J. Pharm. Sci., 92: 2386-2398.
49. Gao, P. and W. Morozowich, 2006. Development of supersaturable self emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin. Drug Discov., 3: 97-110.
50. Gershanik, T. and S. Benita, 1996. Positively charged self-emulsifying oil formulation for improving oral bioavailability of progesterone. Pharm. Dev. Technol., 1: 147-157.
51. Gershanik, T. and S. Benita, 2000. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur. J. Pharm. Biopharm., 50: 179-188.
52. Gershanik, T., E. Haltner and S. Benita, 2000. Charge-dependent interaction of s elf-emulsifying oil formulations with Caco-2 cells monolayers: binding, effects on barrier function and cytotoxicity. Int. J. Pharm., 211: 29-36.
53. Gharaei-Fathabad, E., 2011. Bios urf a étants in pharmaceutical industry: A mini-review. Am. J. Drug Discovery Dev., 1: 58-69.
54. Ghosh, P.K., M.L. Umrethia and R.J. Majethiya, 2004. Preparation and Physicochemical characterisation of caprylocapryl macrogol-8-glycerides microemulsion for oral drug delivery. Ars. Pharm., 45: 353-372.
55. Giri, T.K., A. Alexander and D.K. Tripathi, 2010a. Physicochemical classification and formulation development of solid dispersion of poorly water soluble drugs: An updated review. Int. J. Pharm. Biol. Arch., 1: 309-324.
56. Giri, T.K., H. Badwaik, A. Alexander and D.K. Tripathi, 2010b. Solubility enhancement of ibuprofen in the presence of hydrophilic polymer and surfactant. Int. J. Applied Biol. Pharm. Technol., 1: 793-800.
57. Gokturk, S. and U. Var, 2011. Effect of ethanol on partition and binding equilibrium of phenothiazine in anionic and nonionic micellar solutions. Curr. Res. Chem., 3: 49-61.
58. Grove, M., A. Mullertz, J.L. Nielsen and G.P. Pedersen, 2006. Bioavailability of seocalcitol 11: Development and characterisation of Self-Microemulsifying Drug Delivery Systems (SMEDDS) for oral administration containing medium and long chain triglycerides. Eur. J. Pharm. Sci., 28: 233-242.
59. Gursoy, N.R. and S. Benita, 2004. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophylic drugs. J. Biomed. Pharmacother., 58: 173-182.
60. Hauss, D.J., S.E. Fogal, J.V Ficorilh, C.A. Price, T. Roy, A.A. Jayaraj and J.J. Keirns, 1998. Lipid- based delivery systems for improving the bioavailability and lymphatic transport of a poorly water soluble LTB4 inhibitor. J. Pharm. Sci., 87: 164-169.
61. Hauss, D.J., 2007. Oral lipid-based formulations. Adv. Drug Delivery Rev., 59: 667-676.
62. Hauss D.J., S.C. Mehta and G.W. Radebaugh, 2007. Targeted lymphatic transport and modified systemic distribution of Cl-976: A lipophilic lipidregulator drug, via a formulation approach. Int. J. Pharma., 108: 85-93.
63. Hoar, T.P. and J.H. Schulman, 1943. Transparent water-in-oil dispersions: The oleopathic hydromicelle. Nature, 152: 102-103.
64. Hong, J.Y., J.K. Kim, Y.K. Song, J.S. Park and C.K. Kim, 2006. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J. Control Release, 110: 332-338.
65. Hoque, M.Z., K.M. Hossain and F. Akter, 2009. The effect of lecithin-a non-absorbing emulsifying agent on cookie production. Pak. J. Nutr., 8: 1074-1077.
66. Itoh, K., Y. Tozuka, T. Oguchi and K. Yamamoto, 2002. Improvement of physicochemical properties of N-4472 part 1 formulation design by using self-microemulsifying system. Int. J. Pharmaceutics, 238: 153-160.
67. Julianto, T., K.H. Yuen and A.M. Noor, 2000. Improved bioavailability of vitamin E with a self emulsifying formulation. Int. J. Pharm., 2: 53-57.
68. Kadu, P.J., S.S. Kushare, D.D. Thacker and S.G. Gattani, 2011. Enhancement of oral bioavailability of atorvastatin calcium by Self-Emulsifying Drug Delivery Systems (SEDDS). Pharm. Dev. Technol., 16: 65-74.
69. Kang, B., J. Lee and S. Chon, 2004a. Improved oral delivery of lipophilic drugs. Biomed. Pharmacothe., 58: 173-182.
70. Kang, B.K., J.S. Lee, S.K. Chon, S.Y. Jeong and S.H. Yuk et al, 2004b. Development of self- microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm., 274: 65-73.
71. Kanika, S., Y. Pawar, B. Bansal and K. Arvind, 2010. Self emulsifying drug delivery system: A Strategy To Improve Oral Bioavailability. Current Res. Inform. Sci., 3: 42-49.
72. Kassem, A.A., M.A. Marzouk, A.A. Ammar and G.H. Elosaily, 2010. Preparation and in vitro evaluation of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) containing clotrimazole. Drug Discoveries Ther., 4: 373-379.
73. Khan, M., A. Nazzal and Sami, 2009. Eutectic-based self-nanoemulsified drug delivery system. US Patent 7588786.
74. Khoo, S.M., A.J. Humberstone, C.J.H. Porter, G.A. Edwards and W.N. Charman, 1998. Formulation design and bioavailability assessment of lipid self emulsifying formulations of halofantrin. Int. J. Pharm., 167: 155-164.
75. Kim, J.Y. and Y.S. Ku, 2000. Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats. Int. J. Pharm., 19: 81-89.
76. Kim, H.J., K.A. Yoon, M. Hahn, E.S. Park and S.C. Chi, 2000. Preparation and In Vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev. Ind. Pharm., 26: 523-529.
77. Kim, G.H., J.Y. Lee, Y. Kang, K.N. Kang and E.S. Kim et al, 2011. Preparation and characterization of self-emulsified docetaxel. J. Nanomaterials, 3: 33-41.
78. Kimura, M., M. Shizuki, K. Miyoshi, T. Sakai, H. Hidaka, H. Takamura and T. Matoba, 1994. Relationship between the molecular structures and emulsification properties of edible oils. Biosci. Biotech. Biochem., 58: 1258-1261.
79. Kohli, K., S. Chopra, D. Dhar, S. Arora and R.K. Khar, 2010. Self emulsifying drug delivery system: An approach to enhance the oral bioavailability. Drug Discov. Today, 15: 958-965.
80. Kumar, M.S., P. Shailaja and K.V.R. Murthy, 2011. Improvement of oral bioavailability of nifedipine through self microemulsifing drug delivery systems. J. Global Trends Pharm. Sci., 2: 364-388.
81. Lawrence, M.J. and G.D. Rees, 2000. Microemulsion-based media as novel drug delivery systems. Adv. Drug Delivery Rev., 45: 89-121.
82. Lee and B. Jin, 2004. Compositions containing itraconazole and their preparation methods. US Patent Application 20040248901.
83. Legen and Igor, 2010. Self-microemulsifying drug delivery systems. US Patent Application 20100331356.
84. Li, P., A. Ghosh, F. Robert, S. Krill, M.J. Yatindra and T.M. Abu, 2005. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulisons. Int. J. Pharma., 288: 27-34.
85. Li, X.R., Y.S. Pel, Y.Q. Huang, Y.X. Zhou, Y.C. Zhang and Y. Liu, 2009. In vitro and in vivo evaluation of a self microemulsifying drug delivery system for silybin. J. Chin. Pharm. Sci., 18: 342-347.
86. Lin and Jing, 2006. Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme QIO. US Patent Application 20060275358.
87. Liu, Y., P. Zhang, N. Feng, X. Zhang, S. Wu and J. Zhao, 2009. Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin. Int. J. Pharm., 365: 136-142.
88. Lm, Y., Z.Q. Chen, X. Zhang, N.P. Feng, J.H. Zhao, S. Wu and R. Tan, 2010. An Improved Formulation Screening and Optimization Method Applied to the Development of a Self- Microemulsifying Drug Delivery System. Chem. Pharm. Bull., 58: 16-22.
89. Liu, Y.O., J.M. Fan, X.Q. Wang and Q. Zhang, 2011. Preparation of sorafenib self- microemulsifying drug delivery system and its relative bioavailability in rats. J. Chin. Pharm. Sci., 20: 164-170.
90. Liu, Zhentao, Yang, Liying and Yang, 2008. Butylphthalide self-emulsifying drug delivery system, its preparation method and application. US Patent Application 20080319056.
91. Mandai, S. and S.S. Mandai, 2011. Microemulsion drug delivery system: A platform for improving dissolution rate of poorly water soluble drug. Int. J. Pharm. Sci. Nanotechnol., 3: 1214-1219.
92. Mandawgade, S.D., S. Sharma, S. Pathak and V.B. Patravale, 2008. Development of SMEDDS using natural lipophile: Application to P-Artemether delivery. Int. J. Pharm., 362: 179-183.
93. Mercuri, A., A. Passalacqua, M.S.J. Wickham, P.M. Faulks, D.Q.M. Craig and S.A. Barker, 2011. The effect of composition and gastric conditions on the self- emulsification process of ibuprofen- loaded self emulsifying drug delivery systems: A microscopic and dynamic gastric model study. Pharm. Res., 28: 1540-1551.
94. Muherei, M.A. and R. Junin, 2009. Investigating synergism in critical micelle concentration of anionic-nonionic surfactant mixtures: surface versus interfacial tension techniques. Asian J. Applied Sci., 2: 115-127.
95. Mullertz, A., A. Ogbonna, S. Ren and T. Rades, 2010. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. J. Pharm. Pharmacol., 62: 1622-1636.
96. Mulye and Nirmal, 2000. Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system. US Patent 6057289.
97. Mulye and Nirmal, 2002. Self-emulsifying compositions for drugs poorly soluble in water. US Patent 6436430.
98. Muranishi, S., 1990. Absorption enhancers. Crit. Rev. Ther. Drug Carr, 7: 1-34.
99. Myers, R.A. and V.J. Stella, 1992. Factors affecting the lymphatic transport of penclomedine (NSC- 338720), a lipophilic cytotoxic drug: comparison to DDT and hexachlorobenzene. Int. J. Pharm., 80: 51-62.
100. Natesan, S., R. Subhabrata, K.G. Saroj, B. Ranjan and P.M. Satya, 2004. Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol. Pharm. Bull., 27: 1993-1999.
101. Nazzal, S. and M.A. Khan, 2006. Controlled drug release of a self-emulsifying formulation from a tablet dosage form: Stability assessment and optimization of some processing parameters. Int. J. Pharm., 315: 110-121.
102. Nekkanti, V.K., P. Karatgi, R. Prabhu and R. Pillai, 2010. Solid Self-microemulsifying formulation for candesartan cilexetil. AAPS Pharm. Sci. Tech., 11: 9-17.
103. Nerurkar, M.M., P.S. Burton and R.T. Borchardt, 1996. The use of surfactants to enhance the permeability of peptides through Caco-cells by inhibition of an apically polarized efflux system. Pharm. Res., 13: 528-534.
104. O'Driscoll, C.M. and B.T. Griffin, 2008. Biopharmaceutical challenges associated with drugs with low aqueous solubility- the potential impact of lipid-based formulations. Adv. Drug Deliv. Rev., 60: 617-624.
105. Oostendorp, R.L., T. Buckle, G. Lambert, J.S. Garrigue, J.H. Beijnen, J.H.M. Schellens and O.V. Tellingen, 2011. Paclitaxel in self-micro emulsifying formulations: Oral bioavailability study in mice. Invest New Drugs, 29: 768-776.
106. Osol, A., 1975. Emulsifying and Suspending Agents. 15th Edn., Mack Publishing, USA., pp: 1246.
107. Ozawa, K., U. Olsson and H. Kunieda, 1986. Oil-induced structural change in nonionic microemulsions. J. Dispersion Sci. Technol., 22: 119-124.
108. Patel, A.R. and P.R. Vavia, 2007. Preparation and in vivo evaluation of SMEDDS (self- microemulsifying drug delivery system) containing fenofibrate. AAPS J., 9: E344-E352.
109. Patel, D. and K.K. Sawant, 2007. Oral bioavailability enhancement of acyclovir by self- microemulsifying drug delivery systems (SMEDDS). Drug Dev. Ind. Pharm., 33: 1318-1326.
110. Patel, D. and K.K. Sawant, 2009. Self micro-emulsifying drug delivery system: Formulation development and biopharmaceutical evaluation of lipophilic drugs. Curre. Drug Delivery, 6: 419-424.
111. Patel, M., S. Patel, N. Patel and M. Patel, 2011. A review: Novel oral lipid based formulation for poorly soluble drugs. Int. J. Pharm. Sci. Nanotechnol., 3: 1182-1192.
112. Patel, M.J., N.M. Patel, R.B. Patel and P.P. Patel, 2010a. Formulation and evaluation of self- microemulsifying drug delivery system of lovastatin. Asian J. Pharm. Sci., 5: 266-275.
113. Patel, V.P., T.R. Desai, P.P. Kapupara, S.A. Atara and R.A. Keraliya, 2010b. Self emulsifying drug delivery system: A conventional and alternative appproach to improve oral bioavailability of lipophilic drugs. Int. J. Drug Dev. Res., 2: 859-870.
114. Patil, P. and A. Paradkar, 2006. Porous polystyrene beads as carriers for self-emulsifying system containing loratadme. AAPS Pharm. Sci. Technol., 7: E199-E205.
115. Patil, P., P. Joshi and A. Paradkar, 2004. Effect of formulation variables on preparation and evaluation of gelled S elf-Emulsifying Drug Delivery System (SEDDS) of ketoprofen. AAPs PharmSci. Tech., 5: 43-50.
116. Patil, P., V. Patil and A. Paradkar, 2007. Formulation of a self-emulsifying system for oral delivery of simvastatin: In vitro and In vivo evaluation. Acta Pharm., 57: 111-122.
117. Patil, P.R., S. Praveen, R.H.S. Rani and A.R. Paradkar, 2005. Bioavailability assessment of ketoprofen incorporated in gelled self-emulsifying formulation: A technical note. AAPS Pharm. Sci. Technol., 6: E9-E13.
118. Patravale, V.B., A.A. Date and A.A. Kale, 2003. Oral Self microemulsifying system: Potential in DDS. Pharm. Technol. Express Pharm. Pulse Spec. Feature, 29: 44-48.
119. Perlman, M.E., S.B. Murdande, M.J. Gumkowski, T.S. Shah and C.M. Rodricks et al, 2008. Development of a self-emulsifying formulation that reduces the food effect for torcetrapib. Int. J. Pharm., 351: 15-22.
120. Pogori, N., A. Cheikhyoussef, Y. Xu and D. Wang, 2008. Production and biochemical characterization of an extracellular hpase from Rhizopus chinensis CCTCC M201021. Biotechnology, 7: 710-717.
121. Porter, C.J.H. and W.N. Charman, 2001a. In vitro assessment of oral lipid based formulations. Adv. Drug Delivery Rev., 50: S127-S147.
122. Porter, C.J.H. and W.N. Charman, 2001b. Intestinal lymphatic transport: An update. Adv. Drug Delivery Rev., 50: 61-80.
123. Porter, C.J.H., N.L. Trevaskis and W.N. Charman, 2007. Lipids and hpid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov., 6: 231-248.
124. Porter, C.J.H., C.W. Pouton, J.F. Cume, and W.N. Charman, 2008. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv. Drug Delivery Rev., 60: 673-691.
125. Pouton, C.W., 1997. Formulation of self emulsifying drug delivery systems. Adv. Drug Deliv. Rev., 25: 47-58.
126. Pouton, C.W., 2000. Lipid formulations for oral administration of drugs: non-emulsifying, self- emulsifying and self-microemulsifying drug delivery systems. Eur. J. Pharm. Sci., 11: S93-S98.
127. Pouton, C.W., 2006. Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci., 29: 278-287.
128. Pouton, C.W. and C.J. Porter, 2008. Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies. Adv. Drug Deliv. Rev., 60: 625-637.
129. Rad, A.S., 2010. Study on preparation and some properties of panretin-loaded nanocapsules. Biotechnology, 9: 234-237.
130. Ramachandran, S., G. Thirumurugan and M.D. Dhanaraju, 2011. Development and evaluation of biodegradable chitosan microspheres loaded with ranitidine and cross linked with glutaraldehyde. Am. J. Drug Discovery Dev., 1: 105-120.
131. Reddy, L.H. and R.S. Murthy, 2002. Lymphatic transport orally administered drugs. Indian J. Exp. Boil., 40: 1097-1109.
132. Reiss, H., 1975. Entropy-induced dispersion of bulk liquids. J. Colloids Interface Sci., 53: 61-70.
133. Robinson, J.R., 1996. Introduction: Semi-solid formulations for oral drug delivery. Bull. Tech, Gattefosse, 89: 11-13.
134. Seedher, N. and P. Sharma, 2007. Solubility and stability enhancement of poorly-soluble drugs clarithromycin and prednisolone by combination with other drugs. Int. J. Biol. Chem., 1: 229-236.
135. Serratoni, M., M. Newton, S. Booth and A. Clarke, 2007. Controlled drug release from pellets containing water-insoluble drugs dissolved in a s elf-emulsifying system. Eur. J. Pharm. Biopharm., 65: 94-98.
136. Shinde, G., S. Kuchekar, P. Kamble, A. Kuchekar, K.R. Shirsagar and B. Kuchekar, 2011. Self microemulsifying drug delivery system: A novel approach for hydrophobic drugs. Int. J. Pharm. Sci., 3: 988-1005.
137. Singh, A.K., A. Chaurasiya, M. Singh, S.C. Upadhyay, R. Mukherjee and R.K. Khar, 2008. Exemestane loaded Self-Microemulsifying Drug Delivery System (SMEDDS): Development and optimization. AAPS Pharm. Sci. Technol., 9: 628-634.
138. Singh, A.K., A. Chaurasiya, G.K. Jain, A. Awasthi and D. Asati et al., 2009a. High performance liquid chromatography method for the pharmacokinetic study of bicalutamide SMEDDS and suspension formulations after oral administration to rats. Talanta, 78: 1310-1314.
139. Singh, B., S. Bandopadhyay, R. Kapil, R. Singh and O. Katare, 2009b. Self-Emulsifying Drug Delivery Systems (SEDDS): Formulation development, characterization and applications. Crit. Rev. Thera. Drug Carrier Sys., 26: 427-521.
140. Singh, S.K., P.R.P. Verma and B. Razdan, 2009c. Development and characterization of a carvedilol loaded self-microemulsifying delivery system. Clin. Res. Reg. Affairs, 26: 50-64.
141. Sun, M., L. Si, X. Zhai, Z. Fan, Y. Ma, R. Zhang and X. Yang, 2011. The influence of co-solvents on the stability and bioavailability of rapamycin formulated in self-microemulsifying drug delivery systems. Drug Dev. Industrial Pharm., 37: 986-994.
142. Takada, K. and M. Murakami, 2005. Glycyrrhizin preparations for transmucosal absorption. US Pat 6890547. http://www.findthatpatent.com/Glycyrrhizin_preparations_for_transmucosal_absorption,6890547.html
143. Tan, A., S. Simovic, AK. Davey, T. Rades and C.A. Prestidge, 2009. Sihca-hpid hybrid (SLH) microcapsules: A novel oral delivery system for poorly soluble drugs. J. Control. Release, 134: 32-70.
144. Tang, J.L., J. Sun and Z.G. He, 2007. Self-emulsifying drug delivery systems: Strategy for improving oral delivery of poorly soluble drugs. Curr. Drug Ther., 2: 85-93.
145. Tapas, A.R., P.S. Kawtikwar and D.M. Sakarkar, 2011. Modification of felodipine properties using spherically agglomerated solid dispersions. Am. J. Drug Discovery Dev., 1: 160-173.
146. Thia, T.D., M.V. Speybroeck, V. Barillaro, J. Martensb and P. Annaerta et al., 2009. Formulate- ability often compounds with different physicochemical profiles in SMEDDS. Eur. J. Pharm. Sci., 38: 479-488.
147. Trickier, W.J.A., 2008. Novel nanoparticle formulation for sustained paclitaxel Delivery. AAPS Pharm. Sci. Technol., 9: 486-493.
148. Tripathi, D.K., S.K. Ghosal and D. Panda, 1994. Rheological characterization of CMC for formulating some pharmaceutical suspensions. J. Polym. Mater., 11: 141-146.
149. Venkatesh, G., M.I.A. Majid, S.M. Mansor, N.K. Nair, S.L. Croft and V. Navaratnam, 2010. In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone. Drug Dev. Ind. Pharm., 36: 735-743.
150. Wanwimolruk, S. and G. Levy, 1987. Effect of age on the pharmacodynamics of phénobarbital and ethanol in rats. J. Pharm. Sci., 76: 503-507.
151. Wanwimolruk, S., J.R. Denton, D.G. Ferry, M. Beasley and J.R. Broughton, 1992. Polymorphism of debrisoquine oxidation in New Zealand Caucasians. Eur. J. Clin. Pharmacol., 43: 349-350.
152. Wanwimolruk, S., H. Zhang, P.C. Coville, D.J. Saville and L.S. Davis, 1999. In vitro hepatic metabolism of CYP3A-mediated drug, quinine in the Antarctic Adelie penguins. Compar. Biochem. Physiol., 124C: 301-307.
153. Wasan, E.K., K. Bartlett, P. Gershkovich, O. Sivak and B. Banno et al., 2009. Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans. Int. J. Pharm., 372: 76-84.
154. Wu, W., Y. Wang and L. Que, 2006. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur. J. Pharm. Biopharma., 63: 288-294.
155. Yadav, O.P., Y.K. Yadav, A.R. Das, T. Dey, S. Kakkar and M.L. Singlav, 2008. Catalytic oxidation of carbonmonoxide using platinum nanoparticles synthesized in microemulsion. Asian J. Scient. Res., 1: 79-84.
156. Yao, G. and Y. Li, 2010. Preparation, characterization and evaluation of self-microemulsifying drug delivery systems (SMEDDSs) of Ligusticum chuanxiong oil. Biomed. Pharmacother., 1: 1-6.
157. Yap, S.P. and K.H. Yuen, 2004. Influence of lipolysis and droplet size on tocotrienol absorption from self-emulsifying formulations. Int. J. Pharm., 281: 67-78.
158. Yi, T., J. Wan, H. Xu and X. Yang, 2008. Controlled poorly soluble drug release from solid self- microemulsifying formulations with high viscosity hydroxypropylmethylcellulose. Eur. J. Pharm. Sci., 34: 274-280.
159. Zadeh, B.S.M., H. Moghimi, P. Santos, J. Hadgraft, M.E. Lane and F. Rahim, 2010. Formulation of microemulsion systems for improvement of nitrofurazone permeation through silicon membrane as burn wound imitating coverage. Int. J. Pharmacol., 6: 264-270.
160. Zhang, P., Y. Liu, N. Feng and J. Xu, 2008. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int. J. Pharm., 355: 269-276.
161. Zhao, Y., C. Wang, A.H.L Chow, K. Ren, T. Gong, Z. Zhang and Y. Zheng, 2010. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: Formulation and bioavailability studies. Int. J. Pharm., 383: 170-177.
162. Zvonar, A., K. Berginc, A. Kristl and M. Gasperlin, 2010. Microencapsulation of self-microemulsifying system: Improving solubility and permeability of furosemide. Int. J. Pharm., 388: 151-158.